Keala Milles, Contributing Author at MarketBeat About Keala MillesContributing Author: HealthCare and PharmaKeala is an experienced freelance writer and has written for a wide variety of websites and has covered many topics, from stock market tips to consumer goods, with a specialty in healthcare and pharmaceutical stocks. He has experience with aggregate news writing, press releases and content pages. His strong media and communication background includes a bachelor of arts degree focused on drama and dramatics/theater arts from the University of Washington.Contact Keala Milles via email at kealamilles@gmail.com.Articles by Keala MillesMergers and Acquisitions in 2023 Off To A Strong StartJanuary 26th, 2023 8:17 AMMergers and acquisitions are common, especially across the health sector. Here are some lesser-known buyouts and how they could fare down the road. How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?January 25th, 2023 4:03 AMFive biotechs have already issued layoffs in 2023. Many seem to have good potential, but time will tell if the shifts create the value analysts anticipate. Low-Priced Stocks Still Paying DividendsJanuary 24th, 2023 7:00 AMThese stocks fell last year, which helped boost their dividends. Now around $10 a share each, they offer great value, but could also have more risk. Does a Price Cut for Tesla Vehicles Mean the Same for TSLA Stock?January 19th, 2023 11:40 AMTesla announced price cuts on popular models in order to boost sales, after several earnings misses. Hopefull this can build momentum to restore stock valueWhy is T-mobile Down Despite Strong Preliminary Q4 Results?January 19th, 2023 9:19 AMDespite a positive preliminary earnings report, Tmobile stock is slipping. This article investigates some of the factors that may be contributing to the dip. Does it Matter Folks Aren't “Starry-Eyed” Over Pepsi's New Soda?January 18th, 2023 5:00 AMPepsi introduced a new lemon-lime beverage, "Starry" to somewhat poor reception, but that does not seem to affect long-term growth. 3 Small-Cap Biopharma Stocks that Could See Big Growth in 2023January 13th, 2023 3:00 AMHealth care stocks are trying to make a comeback and these three small-cap biopharma companies are leading the charge in some ways.2 Biotechs Making Waves With A Single Product in their PipelineJanuary 11th, 2023 10:10 AMCatalyst Pharmaceuticals and Harmony Bioscience each have a single product in their respective pipelines, and both show incredible promise. What Does Amazon's Acquisition of 1LifeMedical Mean To Investors?January 10th, 2023 3:00 AMAfter the announcement in July, the Amazon acquisition of One Medical is complete. What does this deal mean for healthcare or tech investors?Four Undervalued Healthcare Stocks for 2023January 6th, 2023 11:20 AMThese four health care stocks could be undervalued: Pfizer Inc., Regeneron Pharmaceuticals Inc., Innoviva Inc. and Exelixis Inc. How 2022's Biggest Healthcare Gainers Could Fare In 2023January 6th, 2023 8:00 AMHealth care stocks were hit hard early in the pandemic but these three have made quite a comeback. This article examines where they could go in 20233 Health Care Stocks Paying Reliable DividendsJanuary 5th, 2023 1:00 AMPremier Inc, Patterson Companies, Inc, and Walgreens Boots Alliance, Inc are three healthcare stocks consistently paying decent-to-great dividendsIs Kintara Therapeutics A Hidden Gem?December 30th, 2022 1:00 AMKintara Therapeutics' earnings are in the red but impressive FDA approvals could satisfy an extreme upside potential to bring them solvent by next year. Big Health Care Stocks to Watch in the New YearDecember 29th, 2022 1:00 AMHere are three health care stocks to watch as the New Year begins. Two have a moderate Buy rating while one is a Hold, for now. Why Did Immutep Ltd Stock Soar Recently?December 28th, 2022 2:00 AMAnalysts and investors alike appear enamored with Immutep Ltd, whose earnings are growing; more of which could come from their latest product candidate. Three Healthcare Penny Stocks to Watch In The New YearDecember 27th, 2022 1:00 AMThese three penny (and nickel) stocks in the healthcare sector have a lot of potential for 2023, and definitely worth watching. Why Did Viking Therapeutics Stock SkyrocketDecember 21st, 2022 10:00 AMVKTX stock is young but strong and they have excellent potential, particularly following successful trial results from Madrigal Pharma's recent drug trial. Eli Lilly Expects Enduring Growth, Despite Immediate ChallengesDecember 19th, 2022 1:00 PMEli Lilly & Co may be struggling with supply-side issues but new partnerships and a healthy dividend are helping to keep up their momentumCan FDA Approval Bolster DexCom, Inc.?December 14th, 2022 1:00 AMDexcom is relying on the interest and sales of its new continuous glucose monitor--which recently received FDA approval--to boost revenue (and stock value). Can Cano Health Recover From the Recent Sell-Off?December 12th, 2022 8:00 AMRevenue loss and a recent sell-off confirm that Cano Health stock may be struggling right now but a membership-focused strategy could help them recover.Costco vs Amazon: an end of the year showdownDecember 9th, 2022 8:00 AMHow do Costco Wholesale and Amazon.com compare at the end of the year, and does this information affect their moderate buy ratings?Discount Retailers Could Make Good Bargain StocksDecember 9th, 2022 7:00 AMDiscount retailers can be strong stock investments as their share price is often more appealing though they are not always reliable3 Big Box Retail Bets for the HolidaysDecember 6th, 2022 12:00 PMChristmas time tends to be big for retailers, which can make them good bets for investors. Here are three moderate buy stocks as we approach year's end. Why CSL Ltd Stock Could Be Worth a LookDecember 3rd, 2022 2:00 AMFDA approval of costly--but worthwhile--drug leads the momentum that could make CSL Ltd an equally worthwhile investment. Okta Inc Celebrates Earnings Beat But Can They Sustain the Boost?December 2nd, 2022 12:00 PMOkta is struggling but a recent earnings beat has boosted expectations. Can they maintain this momentum and get out of the red?Struggling Axsome Stock Could Bounce Back on Drug Trial SuccessNovember 30th, 2022 8:00 AMAxsome Pharmaceuticals may be struggling to get out of the red but the success of two very recent drug trials could quickly change all of that. Is Snowflake Poised for A Rebound After Its Recent Tumble?November 28th, 2022 11:00 AMThe cloud computing industry appears to be slowing but many stocks in the sector are a moderate buy. This means long term outlook is positive. Can Rambus Maintain Momentum to Regain Recent Losses?November 28th, 2022 1:34 AMRambus Inc grew quickly since its ipo but slipped lately. Rebounds tend to grow further, though, so analysts think it could continue this trendSalesforce Cuts Labor, Shows Strong Earnings Despite ChallengesNovember 23rd, 2022 12:00 PMSalesforce, climbing out of a rough spot, still may not make the best short-term investment. In the future, it could make a big move.Cisco Systems Hopes Restructuring Cuts Costs to Drive RevenueNovember 22nd, 2022 10:00 AMCisco Systems has expanded operations and expect revenue to grow but have recently announced a restructuring plan that could help. Is This The Right Time to Invest in Alibaba?November 22nd, 2022 5:00 AMWithout the ability to turn significant profits, Alibaba is struggling. Fortunately, the industry as a whole is facing challenges, so watch the sector closely.Is Ardelyx is A Buy After Slip in Early 2022November 21st, 2022 1:00 PMArdelyx is relatively new to the market and was doing well until a small drug approval issue last year. Strong earnings and smart partnerships could save themSolid Earnings and Potential Growth Make Costco a Moderate BuyNovember 17th, 2022 1:00 AMCostco has had strong earnings and analysts project the growth will continue but comparable data shows this may be consistent across the industryFour Healthcare Stocks To Watch This WeekNovember 16th, 2022 8:00 AMHealthcare has long been a wise investment, as the industry consistently grows yearly. Some analysts believe that trend will continue.Three Penny Stocks Making Big Moves In NovemberNovember 15th, 2022 8:00 AMPenny stocks are cheap, but risky because they can shift quickly and in big ways. Here are two penny stocks making moves up and one heading down. Vision Hydrogen, Now Vision Energy, Puts Hopes In Stock SplitNovember 11th, 2022 1:00 AMVision Hydrogen Corporation decalred 2-for-1 split and changed their name to Vision Energy; Along with their green energy projects, this should entice investorsAnalysts Rate DraftKings a Moderate Buy As Growth SlowsNovember 10th, 2022 1:00 AMDraftKings share price continues to slip, even with a revenue beat and fewer losses than expected, and analysts have rated the stock a moderate Buy.DoorDash Outperforms Despite Losses - Is It Time To Buy?November 10th, 2022 1:00 AMDoorDash has not done too well since its IPO but in a couple years, sales have improved greatly. Don't let sluggish earnings deter you from a potential buy. Despite Financials, Twilio is One To WatchNovember 8th, 2022 7:00 AMTwilio's financials suggest uncertainty but analysts believe a rebound may be coming soon, as they give it a HOLD rating. Mixed Results Actually Bring More Optimism than Risk for AMDNovember 4th, 2022 1:00 AMAMD is down but this could be the start of another rebound as sales and earnings show promise in the long term, particularly when compared against competitors. Paypal Shows Promise With Strong Buy RatingNovember 3rd, 2022 7:00 AMAnalysts believe Paypal could be a Strong Buy as earnings are not only steady but growing, even amid tough competition; thanks to resilient sales. New Revenue Strategy, Strong Earnings, Apple Remains a BuyNovember 3rd, 2022 1:13 AMApple could have better long-term promise than its peers and industry thanks to strong earnings and a new revenue strategy.The Trade Desk Has Room and Momentum For GrowthNovember 2nd, 2022 2:00 AMTTD may not always have the best numbers but they consistently outpace their competitors and have excellent guidance for the next quarter and full-year. ExxonMobil Stock is Rising. Is it Time to Buy?October 25th, 2022 12:00 PMExxonMobil stock started the year strong and growth may beat others in the black gold industry. Analysts have given ExxonMobil a "moderate buy" ratingImpressive Numbers Could Mean Netflix on the Way BackOctober 21st, 2022 1:00 AMNew subscriptions have helped raise NFLX guidance, but extreme volatility keep analyst to a conservative HOLD rating, awaiting the next earnings report. With Stable Growth, Do Analysts Believe NEE Is a Good BUY?October 18th, 2022 8:00 AMNextEra Energy may not always have better numbers than competitors, but steady growth and an impressive upside could make it a worthy investment.Eli Lilly Stock is a Strong Buy After New Drug ApprovalOctober 17th, 2022 1:00 AMAnalysts seem to agree that steady and stable growth coupled with a potentially best-selling T2D medication makes LLY a STRONG BUYDoes Kraft Heinz Company's Steady Stability Make it a Smart Buy?October 13th, 2022 11:00 AMDespite a small pandemic hiccup, Kraft Heinz shows great solid earnings and strong momentum promise. But is it a portfolio-worthy consumer staples heavy hitter?APA Corporation: An Energy Stock on the MoveOctober 11th, 2022 10:00 AMAPA Corporation stock holds strong while other energy companies struggle. Is the a safer and more affordable option than competitors?Consistent Growth Could Make General Motors a Smart BuyOctober 6th, 2022 11:00 AMGeneral Motors' consistent earnings beats compared to the rest of the industry coupled with strong outlook makes it tempting for investors. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.